GreeneStone to Expand Focus on Addiction Treatment

Company to Divest Endoscopy Subsidiary


TORONTO, Sept. 15, 2014 (GLOBE NEWSWIRE) -- The Board of Directors of GreeneStone Healthcare Corporation (OTCBB:GRST) ("GreeneStone" "GRST" or the "Company"), a provider of healthcare services including Addiction and Mental Health, has approved a plan to become more specialized with a greater focus on the company's addiction treatment businesses. As part of this repositioning, the Board has also voted to divest its endoscopy subsidiary.

GreeneStone's addiction treatment division has increased its revenues significantly over the last several months as a result of greater recognition related to the in-house treatment of a series of high profile clients. The Board has determined that it is in the best interest of shareholders to direct full attention and assets to its Addiction and Mental Health business which can be grown organically, and via acquisition opportunities in Canada and the United States. GreeneStone is currently in negotiations to sell its endoscopy subsidiary with an affiliated group of doctors that has been involved with the operations of this business division. The Company expects to come to final terms and aims to complete the divestiture within the next 30 days.

Shawn Leon, President and CEO, commented, "As our Addiction and Mental Health centers continue to attract attention and grow, we have determined that it is wise to streamline our energies. There are many opportunities for us to expand our services and reach entirely new markets using the programs and procedures supervised by our outstanding team of professionals that are well-established, proven and garnering worldwide recognition."

Regarding the divestiture, Leon explained: "The Endoscopy business was our first healthcare business. Fortunately, it is an attractive asset that we can sell, which will allow us to use the proceeds to help fund what we have determined to be our core growth business."

Results from the second quarter have shown that the plan to contain costs has improved profitability. The cost containment, together with increased revenue this current quarter will continue to show further improvements in profitability. Leon added, "The timing is right for us to focus on our core business and to take advantage of the strong interest we have in the treatment we offer.   Our professional team has been doing great work in our treatment center and we are being rewarded for it.   We are proud of the treatment staff and all that they have achieved. GreeneStone has turned a corner and so many of our goals are coming to fruition."

About GreeneStone Healthcare Corporation

GreeneStone Healthcare Corporation (OTCBB:GRST) operates medical and healthcare clinics in Ontario, Canada. GreeneStone's clinics serve to add overflow capacity to an increasingly stretched provincial healthcare system, and provide private alternatives to publicly available healthcare services. Its four medical clinics (three in Toronto, along with a facility in Muskoka, Ontario) offer various medical services, including addiction treatment, endoscopy, minor cosmetic procedures, and executive health care services.  The Company currently has more than 60 employees and is based in North York, Ontario. For more information you can visit our website at www.greenestone.net.

Notice Regarding Forward-Looking Statements

The information contained herein includes forward-looking statements.  These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements.  Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity.  We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.


            

Contact Data